Dr. Jeffrey L Kaine is a Sarasota, Florida based male rheumatologist who is specialized in Rheumatology. Active license number of Dr. Jeffrey L Kaine for Rheumatology is ME48193 in Florida. Dr. Jeffrey L Kaine treat joint disease similar to orthopedists but do not perform surgeries. He diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Dr. Jeffrey L Kaine speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1154308427
NPI Enumeration Date:
28 Dec, 2005
NPI Last Update On:
11 Sep, 2014
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Jeffrey L Kaine are as mentioned below.
License Number
Specialization
State
Status
ME48193
Rheumatologist
Florida
Primary
Other Medical Identifiers:
Other legacy medical identifiers associated with Dr. Jeffrey L Kaine such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
493662
Other
AETNA
73279
Other
Florida
BCBS
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1945 Versailles St, 2nd Floor Sarasota, Florida
Zip:
34239-6900
Phone Number:
941-365-0770
Fax Number:
941-955-4536
Patients can reach Dr. Jeffrey L Kaine at 1945 Versailles St, 2nd Floor, Sarasota, Florida or can call to book an appointment on 941-365-0770. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.